Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Pursuing Fusion & Application of Intellectual Property: Mr Nakamura of Nippon Kayaku
October 7, 2002
- Fujisawa to Enhance Profitability by Splitting Off Plants, Chemical Division
October 7, 2002
- REGULATORY NEWS IN BRIEF
October 7, 2002
- Nippon Chemiphar Ties Up with Ranbaxy of India
October 7, 2002
- JPMA to Gear Up Efforts to Protect IP
October 7, 2002
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
October 7, 2002
- Dr Sakaguchi Shows Direction for Medical Fee System Reform: Economist Conferences
October 7, 2002
- Korosho to Develop Drug Safety Prediction System
September 30, 2002
- BD Japan: BD BBL CultureSwab EZII
September 30, 2002
- Drafting of GL for Physician-led Clinical Trials Progresses
September 30, 2002
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
September 30, 2002
- Ivermectin, Micafungin Recommended for Approval
September 30, 2002
- FDA's Registration Criteria for Drugs to Treat Obesity Outlined: JHSF Seminar
September 30, 2002
- Korosho to Shortly Propose Policy for Health Insurance Reform: Senior Official
September 30, 2002
- b-blockers Not Always More Effective than Ca Antagonists
September 30, 2002
- BUSINESS NEWS IN BRIEF
September 30, 2002
- COLIN Medical Instruments Receives FDA Approval for Prodigy
September 30, 2002
- NEW PRODUCTS
September 30, 2002
- Terumo Prepares CD-ROM on Proper Use of Drip Infusion Pumps
September 30, 2002
- Kyorin Revises Business Forecasts Downward
September 30, 2002
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…